TY - JOUR T1 - Do dietary and physical activity interventions in adolescents provide a cost-effective use of healthcare resources? Model development and illustration based on the Engaging Adolescents in Changing Behaviour (EACH-B) programme JF - medRxiv DO - 10.1101/2021.05.05.21256672 SP - 2021.05.05.21256672 AU - Neelam Kalita AU - Keith Cooper AU - Janis Baird AU - Kathryn Woods-Townsend AU - Keith M Godfrey AU - Cyrus Cooper AU - Hazel Inskip AU - Mary Barker AU - Joanne Lord AU - the EACH-B study group Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/08/2021.05.05.21256672.abstract N2 - Objective To assess costs, health outcomes and cost-effectiveness of interventions that aim to improve quality of diet and level of physical activity in adolescents.Design A Markov model was developed to assess four potential benefits of healthy behaviour for adolescents: better mental health, Type 2 diabetes, higher earnings and reduced incidences of adverse pregnancy outcomes. The model parameters were informed by published literature. The analysis took a societal perspective over a 20-year period. One-way and probabilistic sensitivity analyses were conducted.Setting Secondary schools.Participants A hypothetical cohort of adolescents aged 12-13 years.Interventions An exemplar school-based, multi-component intervention that was developed by the Engaging Adolescents for Changing Behaviour programme, compared with usual schooling.Primary and secondary outcome measures Incremental cost-effectiveness ratio as measured by cost per quality-adjusted life year (QALY) gained.Results The model suggested that an intervention for improving diet and physical activity has the potential to offer a cost-effective use of healthcare resources for adolescents in the UK at a willingness-to-pay threshold of £20,000 per QALY. The key model drivers are the intervention effect on levels of physical activity, quality of life gain for high levels of physical activity, the duration of the intervention effects and the period over which effects wane.Conclusions The model focused on short to medium-term benefits of healthy eating and physical activity exploiting the strong evidence base that exists for this age group. Other benefits in later life, such as reduced cardiovascular risk, are more sensitive to assumptions about the persistence of behavioural change and discounting.Strengths and limitations of this studyThe study addresses an important public health question by examining if interventions targeting healthy eating and doing more physical activities provide value for money from a societal perspective.A Markov cohort model was developed to assess the costs and benefits, expressed in terms of quality-adjusted life years, of an exemplar school-based, multi-component intervention to improve adolescents’ diet and increase their levels of physical activity.The study incorporates existing evidence on the effect of improvement in adolescent health behaviours on four high prevalence short-to-medium term benefits relevant to young people: improved mental health, higher earnings, improved pregnancy outcomes and prevention of Type 2 diabetes.Extensive sensitivity analyses were conducted to investigate the impact of uncertainty over the model assumptions and parameter inputs, thereby highlighting areas where further research would be most useful.A limitation of the study is that it does not estimate the long-term impacts of such interventions due to the lack of longitudinal data on lifetime trajectories of healthy diet and increased levels of physical activity.Competing Interest StatementKMG has received reimbursement for speaking at conferences sponsored by companies selling nutritional products, and is part of an academic consortium that has received research funding from Abbott Nutrition, Nestec, BenevolentAI Bio Ltd. and Danone. The other authors have no potentially competing interests to declare.Funding StatementThe research is funded by the National Institute for Health Research (RP-PG-0216-20004). HMI and KMG are funded by the UK Medical Research Council (MC_UU_12011/4). KMG is supported by the National Institute for Health Research (NIHR Senior Investigator (NF-SI-0515-10042), NIHR Southampton 1000DaysPlus Global Nutrition Research Group (17/63/154) and NIHR Southampton Biomedical Research Centre (IS-BRC-1215-20004)), the European Union (Erasmus+ Programme ImpENSA 598488-EPP-1-2018-1-DE-EPPKA2-CBHE-JP) and the British Heart Foundation (RG/15/17/3174).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Southampton Ethics CommitteeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData from publicly available sources were used for the model. All model inputs are described in the paper. ER -